{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:05:24Z","timestamp":1785888324381,"version":"3.56.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS110435"],"award-info":[{"award-number":["NS110435"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005331","name":"American Brain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-026-03026-1","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:00:10Z","timestamp":1778576410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular profiling of alpha-synuclein pathology and seeding activity in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"151","author":[{"given":"Zeynep Bengisu","family":"Kaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilyn","family":"Amerna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Susarla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina J.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bregendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"DeTure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suelen L.","family":"Boschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"3026_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41592-019-0530-8","volume":"16","author":"WR Algar","year":"2019","unstructured":"Algar WR, Hildebrandt N, Vogel SS, Medintz IL (2019) FRET as a biomolecular research tool \u2014 understanding its potential while avoiding pitfalls. Nat Methods 16:815\u2013829. https:\/\/doi.org\/10.1038\/s41592-019-0530-8","journal-title":"Nat Methods"},{"key":"3026_CR2","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ et al (2006) Phosphorylation of Ser-129 Is the Dominant Pathological Modification of & #x3b1;-Synuclein in Familial and Sporadic Lewy Body Disease *. J Biol Chem 281:29739\u201329752. https:\/\/doi.org\/10.1074\/jbc.M600933200","journal-title":"J Biol Chem"},{"key":"3026_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120405","volume":"442","author":"E Angelopoulou","year":"2022","unstructured":"Angelopoulou E, Bozi M, Simitsi A-M, Koros C, Antonelou R, Papagiannakis N et al (2022) Clinical differences between early-onset and mid-and-late-onset Parkinson\u2019s disease: data analysis of the Hellenic Biobank of Parkinson\u2019s disease. J Neurol Sci 442:120405. https:\/\/doi.org\/10.1016\/j.jns.2022.120405","journal-title":"J Neurol Sci"},{"key":"3026_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103817","volume":"86","author":"PR Angelova","year":"2025","unstructured":"Angelova PR, Esteras N, Evans J, Kostic M, Melki R, Prehn JHM et al (2025) \u03b1-synuclein fibrils per se but not \u03b1-synuclein seeded aggregation causes mitochondrial dysfunction and cell death in human neurons. Redox Biol 86:103817. https:\/\/doi.org\/10.1016\/j.redox.2025.103817","journal-title":"Redox Biol"},{"key":"3026_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-023-02663-0","volume":"147","author":"GM Bentivenga","year":"2024","unstructured":"Bentivenga GM, Mammana A, Baiardi S, Rossi M, Ticca A, Magliocchetti F et al (2024) Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to lewy body disease stage and pathology burden. Acta Neuropathol 147:18. https:\/\/doi.org\/10.1007\/s00401-023-02663-0","journal-title":"Acta Neuropathol"},{"key":"3026_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"key":"3026_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41531-021-00195-6","volume":"7","author":"AR Braun","year":"2021","unstructured":"Braun AR, Liao EE, Horvath M, Kalra P, Acosta K, Young MC et al (2021) Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors. NPJ Parkinsons Dis 7:52. https:\/\/doi.org\/10.1038\/s41531-021-00195-6","journal-title":"NPJ Parkinsons Dis"},{"key":"3026_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00868-3","volume":"20","author":"M Bregendahl","year":"2025","unstructured":"Bregendahl M, Kaya ZB, Singer W, McLean PJ (2025) Alpha-synuclein seeding amplification assays in Lewy body dementia: a brief review. Mol Neurodegener 20:77. https:\/\/doi.org\/10.1186\/s13024-025-00868-3","journal-title":"Mol Neurodegener"},{"key":"3026_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106078","volume":"122","author":"A Chopra","year":"2024","unstructured":"Chopra A, Lang AE, H\u00f6glinger G, Outeiro TF (2024) Towards a biological diagnosis of PD. Parkinsonism Relat Disord 122:106078. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106078","journal-title":"Parkinsonism Relat Disord"},{"key":"3026_CR10","doi-asserted-by":"publisher","first-page":"eaay3069","DOI":"10.1126\/scitranslmed.aay3069","volume":"12","author":"AA Davis","year":"2020","unstructured":"Davis AA, Inman CE, Wargel ZM, Dube U, Freeberg BM, Galluppi A et al (2020) APOE genotype regulates pathology and disease progression in synucleinopathy. Science Translational Medicine 12:eaay3069. https:\/\/doi.org\/10.1126\/scitranslmed.aay3069","journal-title":"Science Translational Medicine"},{"key":"3026_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40035-019-0164-x","volume":"8","author":"CMG De Luca","year":"2019","unstructured":"De Luca CMG, Elia AE, Portaleone SM, Cazzaniga FA, Rossi M, Bistaffa E et al (2019) Efficient RT-QuIC seeding activity for \u03b1-synuclein in olfactory mucosa samples of patients with Parkinson\u2019s disease and multiple system atrophy. Transl Neurodegener 8:24. https:\/\/doi.org\/10.1186\/s40035-019-0164-x","journal-title":"Transl Neurodegener"},{"key":"3026_CR12","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson DW (2018) Neuropathology of Parkinson disease. Parkinsonism Relat Disord 46:S30\u2013S33. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.07.033","journal-title":"Parkinsonism Relat Disord"},{"key":"3026_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009258","author":"DW Dickson","year":"2012","unstructured":"Dickson DW (2012) Parkinson\u2019s disease and parkinsonism: neuropathology. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a009258","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3026_CR14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41591-020-0938-9","volume":"26","author":"S Dujardin","year":"2020","unstructured":"Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV et al (2020) Tau molecular diversity contributes to clinical heterogeneity in Alzheimer\u2019s disease. Nat Med 26:1256\u20131263. https:\/\/doi.org\/10.1038\/s41591-020-0938-9","journal-title":"Nat Med"},{"key":"3026_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00307-w","volume":"8","author":"SL Farrow","year":"2022","unstructured":"Farrow SL, Cooper AA, O\u2019Sullivan JM (2022) Redefining the hypotheses driving Parkinson\u2019s diseases research. npj Parkinsons Dis 8:45. https:\/\/doi.org\/10.1038\/s41531-022-00307-w","journal-title":"npj Parkinsons Dis"},{"key":"3026_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03948-y","volume":"5","author":"B Frieg","year":"2022","unstructured":"Frieg B, Geraets JA, Stroh\u00e4ker T, Dienemann C, Mavroeidi P, Jung BC et al (2022) Quaternary structure of patient-homogenate amplified \u03b1-synuclein fibrils modulates seeding of endogenous \u03b1-synuclein. Commun Biol 5:1040. https:\/\/doi.org\/10.1038\/s42003-022-03948-y","journal-title":"Commun Biol"},{"key":"3026_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS et al (2002) \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164. https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"key":"3026_CR18","doi-asserted-by":"publisher","DOI":"10.3791\/53205","author":"JL Furman","year":"2015","unstructured":"Furman JL, Holmes BB, Diamond MI (2015) Sensitive detection of proteopathic seeding activity with fret flow cytometry. J Vis Exp. https:\/\/doi.org\/10.3791\/53205","journal-title":"J Vis Exp"},{"key":"3026_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00401-025-02973-5","volume":"151","author":"M Gerasimenko","year":"2026","unstructured":"Gerasimenko M, Yi H, Gilliland T, Chen Y, Wang Z, Zou WQ (2026) Biochemical signatures of skin \u03b1-synuclein in synucleinopathies revealed by RT-QuIC assay end-product analysis. Acta Neuropathol 151:3. https:\/\/doi.org\/10.1007\/s00401-025-02973-5","journal-title":"Acta Neuropathol"},{"key":"3026_CR20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109617119","volume":"119","author":"SS Ghanem","year":"2022","unstructured":"Ghanem SS, Majbour NK, Vaikath NN, Ardah MT, Erskine D, Jensen NM et al (2022) \u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proc Natl Acad Sci U S A 119:e2109617119. https:\/\/doi.org\/10.1073\/pnas.2109617119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3026_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H (2013) 100 years of Lewy pathology. Nat Rev Neurol 9:13\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2012.242","journal-title":"Nat Rev Neurol"},{"key":"3026_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00712-3","volume":"10","author":"T H\u00e4hnel","year":"2024","unstructured":"H\u00e4hnel T, Raschka T, Sapienza S, Klucken J, Glaab E, Corvol J-C et al (2024) Progression subtypes in Parkinson\u2019s disease identified by a data-driven multi cohort analysis. npj Parkinsons Dis 10:95. https:\/\/doi.org\/10.1038\/s41531-024-00712-3","journal-title":"npj Parkinsons Dis"},{"key":"3026_CR23","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1124\/pharmrev.123.001111","volume":"76","author":"K Hassanzadeh","year":"2024","unstructured":"Hassanzadeh K, Liu J, Maddila S, Mouradian MM (2024) Posttranslational modifications of \u03b1-synuclein, their therapeutic potential, and crosstalk in health and neurodegenerative diseases. Pharmacol Rev 76:1254\u20131290. https:\/\/doi.org\/10.1124\/pharmrev.123.001111","journal-title":"Pharmacol Rev"},{"key":"3026_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00368-6","volume":"15","author":"BA Hijaz","year":"2020","unstructured":"Hijaz BA, Volpicelli-Daley LA (2020) Initiation and propagation of \u03b1-synuclein aggregation in the nervous system. Mol Neurodegener 15:19. https:\/\/doi.org\/10.1186\/s13024-020-00368-6","journal-title":"Mol Neurodegener"},{"key":"3026_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W et al (2024) A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 23:191\u2013204. https:\/\/doi.org\/10.1016\/S1474-4422(23)00404-0","journal-title":"Lancet Neurol"},{"key":"3026_CR26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1177\/1877718x241298194","volume":"15","author":"GU H\u00f6glinger","year":"2025","unstructured":"H\u00f6glinger GU, Lang AE (2025) SynNeurGe: the road ahead for a biological definition of Parkinson\u2019s disease. J Parkinsons Dis 15:931\u2013938. https:\/\/doi.org\/10.1177\/1877718x241298194","journal-title":"J Parkinsons Dis"},{"key":"3026_CR27","doi-asserted-by":"publisher","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","volume":"111","author":"BB Holmes","year":"2014","unstructured":"Holmes BB, Furman JL, Mahan TE, Yamasaki TR, Mirbaha H, Eades WC et al (2014) Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci U S A 111:E4376\u2013E4385. https:\/\/doi.org\/10.1073\/pnas.1411649111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3026_CR28","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-022-02421-8","volume":"143","author":"Y Jin","year":"2022","unstructured":"Jin Y, Li F, Sonoustoun B, Kondru NC, Martens YA, Qiao W et al (2022) APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology. Acta Neuropathol 143:641\u2013662. https:\/\/doi.org\/10.1007\/s00401-022-02421-8","journal-title":"Acta Neuropathol"},{"key":"3026_CR29","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.3233\/jpd-223380","volume":"12","author":"A Kolicheski","year":"2022","unstructured":"Kolicheski A, Turcano P, Tamvaka N, McLean PJ, Springer W, Savica R et al (2022) Early-onset Parkinson\u2019s disease: creating the right environment for a genetic disorder. J Parkinsons Dis 12:2353\u20132367. https:\/\/doi.org\/10.3233\/jpd-223380","journal-title":"J Parkinsons Dis"},{"key":"3026_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","volume":"23","author":"A Lau","year":"2020","unstructured":"Lau A, So RWL, Lau HHC, Sang JC, Ruiz-Riquelme A, Fleck SC et al (2020) \u03b1-Synuclein strains target distinct brain regions and cell types. Nat Neurosci 23:21\u201331. https:\/\/doi.org\/10.1038\/s41593-019-0541-x","journal-title":"Nat Neurosci"},{"key":"3026_CR31","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.92775","volume":"13","author":"SS Lee","year":"2024","unstructured":"Lee SS, Civitelli L, Parkkinen L (2024) Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles. Elife 13:RP92775. https:\/\/doi.org\/10.7554\/eLife.92775","journal-title":"Elife"},{"key":"3026_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10231","volume":"6","author":"CH Lo","year":"2021","unstructured":"Lo CH (2021) Recent advances in cellular biosensor technology to investigate tau oligomerization. Bioeng Transl Med 6:e10231. https:\/\/doi.org\/10.1002\/btm2.10231","journal-title":"Bioeng Transl Med"},{"key":"3026_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1750-3639.2012.00585.x","volume":"22","author":"LF Lue","year":"2012","unstructured":"Lue LF, Walker DG, Adler CH, Shill H, Tran H, Akiyama H et al (2012) Biochemical increase in phosphorylated alpha-synuclein precedes histopathology of Lewy-type synucleinopathies. Brain Pathol 22:745\u2013756. https:\/\/doi.org\/10.1111\/j.1750-3639.2012.00585.x","journal-title":"Brain Pathol"},{"key":"3026_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-0716-2597-2_10","volume":"2551","author":"KN Maina","year":"2023","unstructured":"Maina KN, Smet-Nocca C, Bitan G (2023) Using FRET-based biosensor cells to study the seeding activity of Tau and \u03b1-synuclein. Methods Mol Biol 2551:125\u2013145. https:\/\/doi.org\/10.1007\/978-1-0716-2597-2_10","journal-title":"Methods Mol Biol"},{"key":"3026_CR35","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H et al (2013) Prion-like spreading of pathological \u03b1-synuclein in brain. Brain 136:1128\u20131138. https:\/\/doi.org\/10.1093\/brain\/awt037","journal-title":"Brain"},{"key":"3026_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","volume":"8","author":"SY-Y Pang","year":"2019","unstructured":"Pang SY-Y, Ho PW-L, Liu H-F, Leung C-T, Li L, Chang EES et al (2019) The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl Neurodegener 8:23. https:\/\/doi.org\/10.1186\/s40035-019-0165-9","journal-title":"Transl Neurodegener"},{"key":"3026_CR37","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1016\/j.neuron.2023.11.020","volume":"111","author":"LA Parra-Rivas","year":"2023","unstructured":"Parra-Rivas LA, Madhivanan K, Aulston BD, Wang L, Prakashchand DD, Boyer NP et al (2023) Serine-129 phosphorylation of & #x3b1;-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function. Neuron 111:4006-4023.e4010. https:\/\/doi.org\/10.1016\/j.neuron.2023.11.020","journal-title":"Neuron"},{"key":"3026_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-1-4939-9124-2_20","volume-title":"Alpha-Synuclein: methods and protocols","author":"AE Powers","year":"2019","unstructured":"Powers AE, Patel DS (2019) Expression and purification of untagged \u03b1-Synuclein. In: Bartels T (ed) Alpha-Synuclein: methods and protocols. Springer New York, City, pp 261\u2013269"},{"key":"3026_CR39","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1097\/ms9.0000000000001142","volume":"85","author":"P Prajjwal","year":"2023","unstructured":"Prajjwal P, Flores Sanga HS, Acharya K, Tango T, John J, Rodriguez RSC et al (2023) Parkinson\u2019s disease updates: addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment. Ann Med Surg Lond 85:4887\u20134902. https:\/\/doi.org\/10.1097\/ms9.0000000000001142","journal-title":"Ann Med Surg Lond"},{"key":"3026_CR40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/mds.28805","volume":"37","author":"J-L Pu","year":"2022","unstructured":"Pu J-L, Jin C-Y, Wang Z-X, Fang Y, Li Y-L, Xue N-J et al (2022) Apolipoprotein e genotype contributes to motor progression in Parkinson\u2019s disease. Mov Disord 37:196\u2013200. https:\/\/doi.org\/10.1002\/mds.28805","journal-title":"Mov Disord"},{"key":"3026_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-023-00680-x","volume":"18","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam N, Dettmer U (2023) \u03b1-Synuclein serine129 phosphorylation \u2013 the physiology of pathology. Mol Neurodegener 18:84. https:\/\/doi.org\/10.1186\/s13024-023-00680-x","journal-title":"Mol Neurodegener"},{"key":"3026_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00444-w","volume":"9","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam N, Jin S-X, Moors TE, Fonseca-Ornelas L, Shimanaka K, Lei S et al (2023) Dynamic physiological \u03b1-synuclein S129 phosphorylation is driven by neuronal activity. npj Parkinsons Dis 9:4. https:\/\/doi.org\/10.1038\/s41531-023-00444-w","journal-title":"npj Parkinsons Dis"},{"key":"3026_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-025-03013-y","author":"NGD Reyes","year":"2025","unstructured":"Reyes NGD, Pajo AT, Saranza G, H\u00f6glinger GU, Lang AE (2025) Revisiting Parkinson\u2019s disease definition and classification: insights from two emerging biological frameworks. J Neural Transm. https:\/\/doi.org\/10.1007\/s00702-025-03013-y","journal-title":"J Neural Transm"},{"key":"3026_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/jpd-212815","volume":"12","author":"GM Riboldi","year":"2021","unstructured":"Riboldi GM, Frattini E, Monfrini E, Frucht SJ, Di Fonzo A (2021) A practical approach to Early-Onset Parkinsonism. J Parkinsons Dis 12:1\u201326. https:\/\/doi.org\/10.3233\/jpd-212815","journal-title":"J Parkinsons Dis"},{"key":"3026_CR45","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.27193","volume":"32","author":"SA Schneider","year":"2017","unstructured":"Schneider SA, Alcalay RN (2017) Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord 32:1504\u20131523. https:\/\/doi.org\/10.1002\/mds.27193","journal-title":"Mov Disord"},{"key":"3026_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70374","volume":"21","author":"H Sekiya","year":"2025","unstructured":"Sekiya H, Franke L, Ono D, DeTure M, Ross OA, Murray ME et al (2025) Impact of hippocampal \u03b1-synuclein oligomers on cognitive trajectory in patients with dementia with Lewy bodies. Alzheimers Dement 21:e70374. https:\/\/doi.org\/10.1002\/alz.70374","journal-title":"Alzheimers Dement"},{"key":"3026_CR47","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210021","volume":"103","author":"H Sekiya","year":"2024","unstructured":"Sekiya H, Tipton PW, Kawazoe M, Koga S, Murakami A, Maier AR et al (2024) Current landscape of clinical diagnosis in Multiple System Atrophy. Neurology 103:e210021. https:\/\/doi.org\/10.1212\/WNL.0000000000210021","journal-title":"Neurology"},{"key":"3026_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01440-6","volume":"10","author":"H Sekiya","year":"2022","unstructured":"Sekiya H, Tsuji A, Hashimoto Y, Takata M, Koga S, Nishida K et al (2022) Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson\u2019s disease. Acta Neuropathol Commun 10:133. https:\/\/doi.org\/10.1186\/s40478-022-01440-6","journal-title":"Acta Neuropathol Commun"},{"key":"3026_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X et al (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578:273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"key":"3026_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13564-w","volume":"10","author":"T Stroh\u00e4ker","year":"2019","unstructured":"Stroh\u00e4ker T, Jung BC, Liou S-H, Fernandez CO, Riedel D, Becker S et al (2019) Structural heterogeneity of \u03b1-synuclein fibrils amplified from patient brain extracts. Nat Commun 10:5535. https:\/\/doi.org\/10.1038\/s41467-019-13564-w","journal-title":"Nat Commun"},{"key":"3026_CR51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41746-024-01175-9","volume":"7","author":"C Su","year":"2024","unstructured":"Su C, Hou Y, Xu J, Xu Z, Zhou M, Ke A et al (2024) Identification of Parkinson\u2019s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data. npj Digit Med 7:184. https:\/\/doi.org\/10.1038\/s41746-024-01175-9","journal-title":"npj Digit Med"},{"key":"3026_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952","journal-title":"BMJ"},{"key":"3026_CR53","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800. https:\/\/doi.org\/10.1212\/WNL.58.12.1791","journal-title":"Neurology"},{"key":"3026_CR54","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","volume":"139","author":"A Van der Perren","year":"2020","unstructured":"Van der Perren A, Gelders G, Fenyi A, Bousset L, Brito F, Peelaerts W et al (2020) The structural differences between patient-derived \u03b1-synuclein strains dictate characteristics of Parkinson\u2019s disease, multiple system atrophy and dementia with Lewy bodies. Acta Neuropathol 139:977\u20131000. https:\/\/doi.org\/10.1007\/s00401-020-02157-3","journal-title":"Acta Neuropathol"},{"key":"3026_CR55","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","volume":"240","author":"DG Walker","year":"2013","unstructured":"Walker DG, Lue L-F, Adler CH, Shill HA, Caviness JN, Sabbagh MN et al (2013) Changes in properties of serine 129 phosphorylated \u03b1-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol 240:190\u2013204. https:\/\/doi.org\/10.1016\/j.expneurol.2012.11.020","journal-title":"Exp Neurol"},{"key":"3026_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66146-4","volume":"16","author":"F Wang","year":"2025","unstructured":"Wang F, Banerjee V, Barria C, Ramirez S, Allison T, Gorski D et al (2025) Seed amplification of MSA alpha-synuclein aggregates preserves the biological and structural properties of brain-derived aggregates. Nat Commun 16:11266. https:\/\/doi.org\/10.1038\/s41467-025-66146-4","journal-title":"Nat Commun"},{"key":"3026_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07169-9","volume":"23","author":"Z Wang","year":"2025","unstructured":"Wang Z, Li L, Xu Q, Pan H, Wang Y, Long Q et al (2025) The APOE \u03b54 allele affects the survival of patients with Parkinson\u2019s disease independent of dementia. J Transl Med 23:1094. https:\/\/doi.org\/10.1186\/s12967-025-07169-9","journal-title":"J Transl Med"},{"key":"3026_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-025-00469-6","volume":"14","author":"JA Wiseman","year":"2025","unstructured":"Wiseman JA, Turner CP, Faull RLM, Halliday GM, Dieriks BV (2025) Refining \u03b1-synuclein seed amplification assays to distinguish Parkinson\u2019s disease from multiple system atrophy. Transl Neurodegener 14:7. https:\/\/doi.org\/10.1186\/s40035-025-00469-6","journal-title":"Transl Neurodegener"},{"key":"3026_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713199","volume":"24","author":"MJ Wojewska","year":"2023","unstructured":"Wojewska MJ, Otero-Jimenez M, Guijarro-Nuez J, Alegre-Abarrategui J (2023) Beyond strains: molecular diversity in alpha-synuclein at the center of disease heterogeneity. Int J Mol Sci 24:13199","journal-title":"Int J Mol Sci"},{"key":"3026_CR60","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00702-023-02635-4","volume":"130","author":"U W\u00fcllner","year":"2023","unstructured":"W\u00fcllner U, Borghammer P, Choe C-u, Csoti I, Falkenburger B, Gasser T et al (2023) The heterogeneity of Parkinson\u2019s disease. J Neural Transm 130:827\u2013838. https:\/\/doi.org\/10.1007\/s00702-023-02635-4","journal-title":"J Neural Transm"},{"key":"3026_CR61","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","volume":"294","author":"TR Yamasaki","year":"2019","unstructured":"Yamasaki TR, Holmes BB, Furman JL, Dhavale DD, Su BW, Song E-S et al (2019) Parkinson\u2019s disease and multiple system atrophy have distinct \u03b1-synuclein seed characteristics. J Biol Chem 294:1045\u20131058. https:\/\/doi.org\/10.1074\/jbc.RA118.004471","journal-title":"J Biol Chem"},{"key":"3026_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1809","author":"N Zhao","year":"2020","unstructured":"Zhao N, Attrebi ON, Ren Y, Qiao W, Sonustun B, Martens YA et al (2020) APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aay1809","journal-title":"Sci Transl Med"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03026-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-026-03026-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03026-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:00:11Z","timestamp":1778576411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-026-03026-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["3026"],"URL":"https:\/\/doi.org\/10.1007\/s00401-026-03026-1","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"54"}}